Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕CPSE ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFCPSE ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaNippon India
NAV₹29.1863₹91.6982
NAV date20 Nov 202620 Nov 2026
History5.4 years10.0 years
Expense ratio0.2%0.1%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFCPSE ETF
1 month+10.82%+4.04%
3 months+7.43%−1.94%
6 months+14.54%−12.42%
YTD+25.40%+0.08%
1 year+25.57%−1.79%
3 years (CAGR)+22.02%+17.10%
5 years (CAGR)+16.60%+25.18%
10 years (CAGR)—+13.94%
Since launch+14.02%+13.84%

Risk

Nippon India Nifty Pharma ETFCPSE ETF
Volatility15.0%21.3%
Downside volatility9.0%12.3%
Sharpe1.040.50
Sortino1.720.86
Calmar1.330.61
Return / risk1.470.80
Deepest fall−20.98%−54.09%
Days to recover136565
Below its high−1.75%−15.77%

Against benchmark

Nippon India Nifty Pharma ETFCPSE ETF
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFCPSE ETF
Best 1-year+65.21%+134.56%
Middle 1-year+13.46%+11.81%
Worst 1-year−15.30%−46.35%
1-year periods with a loss25.8%36.2%
Middle 3-year+20.51%+24.32%
Positive months61.1%52.8%
Best day+3.64%+7.16%
Worst day−4.03%−15.04%
Worst 5% day−1.62%−1.88%
Positive days54.4%54.3%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFCPSE ETF
5-year XIRR+20.60%+18.89%
5-year value₹10,11,738₹9,69,759
3-year XIRR+19.58%+2.81%
1-year XIRR+34.31%−8.18%

Holdings overlap i

Nippon India Nifty Pharma ETFCPSE ETF
Nippon India Nifty Pharma ETF—0%
CPSE ETF0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

Nippon India Nifty Pharma ETFCPSE ETF
Large companies45.3%86.9%
Mid companies47.1%11.4%
Small companies7.6%1.7%
Top 10 holdings78.6%99.4%
Largest sectorPharmaceuticals & Biotechnology 100%Power 45%

Search Growth